Hirudoid

Hirudoid is a topical medication that contains the active ingredient chondroitin polysulfate. It is supplied in a cutaneous formulation without a specified strength, and it is marketed in the European Union. The product is applied to the skin to address certain localized conditions, and it is classified as a dermatological agent. It is intended for external use only and should be used according to professional guidance.

Hirudoid is commonly employed in the management of superficial skin conditions where inflammation or bruising is present.

- Treatment of bruises and superficial hematomas - Relief of minor sprains and contusions - Reduction of post‑procedural swelling and ecchymosis - Management of mild superficial thrombophlebitis - Adjunct therapy for minor skin irritations after trauma

Adverse reactions to Hirudoid are generally mild, but occasional more serious events have been reported.

Common: - Mild skin irritation or redness at the application site - Itching or a transient burning sensation - Dryness or flaking of the treated skin - Slight tingling or warmth

Serious: - Allergic contact dermatitis - Urticaria or widespread rash - Angioedema involving the face or neck - Severe skin necrosis (rare) - Systemic hypersensitivity reactions

When using Hirudoid, certain precautions should be observed to minimize risk and ensure appropriate use.

- Do not apply to broken, infected, or ulcerated skin - Avoid contact with eyes, mucous membranes, and the genital area - Discontinue use if severe irritation or allergic signs develop - Consult a healthcare professional before use during pregnancy, lactation, or in children - Store at room temperature, protected from excessive heat and direct sunlight - Keep out of reach of children and pets

Topical chondroitin polysulfate may interact with other topical agents or systemic conditions.

Avoid: - Concurrent use of other potent anti‑inflammatory or corticosteroid creams on the same area - Occlusive dressings that may increase systemic absorption - Application over large body surfaces in patients taking systemic anticoagulants due to potential bleeding risk

Use with caution: - Other skin‑sensitizing products such as retinoids or alpha‑hydroxy acids - Herbal or homeopathic preparations applied to the same site - Phototherapy or intense UV exposure - Systemic steroids or immunosuppressants - Patients with known bleeding disorders